Connor, Clark & Lunn Investment Management Ltd. - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 60 filers reported holding OVID THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$256,911
-1.7%
84,233
+3.8%
0.00%0.0%
Q4 2023$261,384
-16.1%
81,175
+0.0%
0.00%
-50.0%
Q3 2023$311,704
+37.2%
81,173
+17.2%
0.00%
+100.0%
Q2 2023$227,130
+185.3%
69,247
+124.4%
0.00%
Q1 2023$79,614
+7.2%
30,858
-22.7%
0.00%
Q4 2022$74,251
-4.8%
39,920
-6.3%
0.00%
-100.0%
Q3 2022$78,000
-1.3%
42,585
+15.9%
0.00%
Q2 2022$79,000
-71.1%
36,748
-57.7%
0.00%
-100.0%
Q1 2022$273,000
-28.9%
86,888
-27.3%
0.00%
-50.0%
Q4 2021$384,000
-42.8%
119,573
-40.1%
0.00%
-50.0%
Q3 2021$671,000
-33.4%
199,573
-22.5%
0.00%
-20.0%
Q2 2021$1,007,000
-0.5%
257,564
+2.3%
0.01%
-16.7%
Q1 2021$1,012,000
+88.8%
251,764
+8.5%
0.01%
+100.0%
Q4 2020$536,000
-37.7%
232,059
+54.7%
0.00%
-50.0%
Q3 2020$861,000
-38.5%
149,989
-21.0%
0.01%
-40.0%
Q2 2020$1,400,000
+196.0%
189,967
+19.8%
0.01%
+150.0%
Q1 2020$473,000158,5870.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 1,490,534$2,77213.66%
Madison Avenue Partners, LP 2,721,051$5,061,1550.90%
Rubric Capital Management LP 6,828,065$12,700,2010.55%
BVF INC/IL 6,851,051$12,742,9550.54%
CHI Advisors LLC 864,822$1,608,5690.43%
EcoR1 Capital, LLC 6,117,400$11,378,3640.35%
Artal Group S.A. 2,500,000$4,6500.26%
Tejara Capital Ltd 107,491$199,9330.12%
Oasis Management Co Ltd. 270,000$502,2000.10%
DCF Advisers, LLC 70,264$130,6910.09%
View complete list of OVID THERAPEUTICS INC shareholders